A spokesperson said that Medtronic didn’t yet know the total number of employees that would be impacted by their new restructuring plan, but that the company is still on track to make good on their pledge to create 1,000 jobs in the state since moving their HQ to Ireland in 2015.
Health Care + Med Tech
Each physician in the state was responsible for an average of $2.3 million in economic activity.
A preclinical study between Mayo and collaborator Corindus Vascular Robotics will test a remote-controlled ‘telestenting’ system in face of likely cardiologist shortfall.
The foundation said it would also donate the same amount and more to 37 organizations, many of which are from Minnesota.
Overall, the company expects to save the $3 billion by the end of its 2022 fiscal year.
Zyga’s flagship product is used to treat chronic pain within the lower spine.
Todd Berg, who led local medical device company Torax Medical to a sale last year, is taking over as CEO of Metavention.
But most hospitals in the state finished in the black with some enjoying big double-digit margins.
University professor Jerrold Vitek and the MnDRIVE program were key in approval for Parkinson’s treatment.
The medical device company expects to get FDA approval for its flagship product this year.
Todd Austin said MGC will now focus on expanding into foreign markets and other growth opportunities.
An Aussie firm with a Twin Cities headquarters is using circadian waves to identify depression types.
Its deal with a Singapore firm backs an AI platform to predict cardiac health events.
Workshops seek to give nurses tools to translate medtech ideas into reality.
The state placed sixth in an annual report from the United Health Foundation.
The sticking point is whether Mayo would then gain the ability to make changes to the benefits packages unilaterally, be they additions or subtractions to the current plans.
Encountering a foreign-born doctor in Greater Minnesota once might have been unusual. If the state’s health-care trends continue as they have, it won’t be much longer.
ZOLL Medical Corporation, a medical device and software firm owned by the Japanese chemical company Asahi Kasei, led the funding round.